Life Science Executive Partnering
March 9-10, 2027Miami, FL, USA Brian MatesicPrincipal at NorwestSpeaker
Profile
Brian is a Principal at Norwest, a $15.5B AUM investment firm, where he invests in biotech and MedTech companies. He has co-led over 10 investments including Ouro Medicines, Nectero Therapeutics, MBX Biosciences, Zenas BioPharma, Avalyn Pharma, and Ray Therapeutics. He is a Board Director at Ouro and has served as Board Observer at Avalyn, MBX, Nectero, and Excision.
Prior to joining Norwest, Brian was an investor at Blackstone Life Sciences, where he helped lead over $1.5B of investments across biotech, medical devices, and diagnostics. Brian started his career at McKinsey & Company. He has a medical degree from Stanford and MBA from Harvard.
Agenda Sessions
The Path to Public: Mastering Your Exit Strategy
, 3:15pmView Session